Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.6800
-0.0200 (-2.86%)
Jul 29, 2025, 2:55 PM AEST
Argenica Therapeutics Revenue
Argenica Therapeutics had revenue of 2.83M AUD in the half year ending December 31, 2024, with 105.66% growth. This brings the company's revenue in the last twelve months to 3.08M, up 13.03% year-over-year. In the fiscal year ending June 30, 2024, Argenica Therapeutics had annual revenue of 2.60M with 48.46% growth.
Revenue (ttm)
3.08M
Revenue Growth
+13.03%
P/S Ratio
28.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
87.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 2.60M | 848.04K | 48.46% |
| Jun 30, 2023 | 1.75M | 1.49M | 575.38% |
| Jun 30, 2022 | 259.10K | -36.98K | -12.49% |
| Jun 30, 2021 | 296.08K | - | - |
| Jun 30, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |